Smoky Mountain Information Systems Home of PIMSY EMR software
2025 Real-World Testing Results Report
§ 170.315(g)(9)
PIMSY Platinum 9.0
General information
- Plan Report ID Number
- Developer Name
- Smoky Mountain Information Systems, LLC
- Product Name(s)
- PIMSY Platinum
- Version Number(s)
- 9.0
- Certified Health IT
- 15.04.04.2342.Pims.09.00.1.231204
- Developer Real World Testing Page URL
- https://pimsyehr.com/mandatorydisclosures/RWT
- Developer Real World Testing Results Page URL
- https://pimsyehr.com/mandatorydisclosures/real-world-test-2025/
Changes to original plan
| Summary of change | Reason | Impact |
|---|---|---|
| The planned §170.315(g)(9) measurement — counting the number of third-party systems or applications connecting to the certified API over a minimum six-month period — could not be completed as designed. The measure was revised to report actual organic usage and to add supplemental functional validation of the certified capability. | No organic patient- or provider-initiated §170.315(g)(9) requests occurred during the CY2025 reporting period. The original testing approach depended on organic third-party application requests, which did not take place. | The actual zero-usage result is reported without substitution. Supplemental validation using synthetic patient data in an environment mirroring production confirms that the certified functionality remained deployed and operational. This approach is consistent with the ONC Real World Testing Resource Guide (October 2025), page 22, “Non-deployed and/or Low Use Capabilities.” |
| Results for §170.315(b)(1) and §170.315(b)(10) are not reported for CY2025. | Per the ONC Real World Testing Condition and Maintenance of Certification Enforcement Discretion Notice, CY2025 results reporting is limited to the API-related certification criteria — §170.315(g)(7), (g)(9) and (g)(10). Among these, PIMSY Platinum is certified only to §170.315(g)(9). | This CY2025 results report addresses §170.315(g)(9) only. |
Withdrawn products
- Product Name(s)
- NA
- Version Number(s)
- NA
- CHPL ID(s)
- NA
- Date(s) Withdrawn
- NA
- Inclusion of Data in Results Report
- NA
Summary of testing methods and key findings
Real World Testing for PIMSY Platinum 9.0 for CY2025 addresses §170.315(g)(9), Application Access — All Data Request. Per the ONC Real World Testing Enforcement Discretion Notice, CY2025 results reporting is limited to the API-related certification criteria, and PIMSY Platinum is certified only to §170.315(g)(9) among those criteria.
The planned measure for §170.315(g)(9) depended on organic requests from patient- or provider-initiated third-party applications connecting to the certified API. No such requests occurred during the CY2025 reporting period. That zero-usage result is reported here as the actual real-world outcome and has not been replaced with a substitute figure.
Because organic usage did not occur, supplemental functional validation was performed to demonstrate that the certified capability remained deployed and operational. Consistent with the ONC Real World Testing Resource Guide (October 2025), page 22, “Non-deployed and/or Low Use Capabilities,” that validation used synthetic patient data in an environment mirroring production, with Postman representing the third-party application. Six validation transactions were executed and all six completed successfully, covering patient selection, an all-data request for a specific date, an all-data request for a specified date range, two negative controls confirming correct date filtering, and retrieval of the resulting C-CDA document.
Key finding: the §170.315(g)(9) capability is deployed and functions as certified, returning a conformant C-CDA Release 2.1 summary record for both a specific date and a specified date range. The limiting factor during CY2025 was the absence of customer demand for third-party application connections, not the availability or correctness of the capability.
Standards updates (including SVAP and USCDI)
- Yes, I have products certified with voluntary SVAP or USCDI standards. (If yes, please complete the table below.)
- No, none of my products include these voluntary standards.
- Standard (and version)
- NA
- Updated certification criteria and associated product
- NA
- Health IT Module CHPL ID
- NA
- Conformance measure
- NA
Care setting
Care setting: Mental Health and Behavioral Health (Ambulatory).
PIMSY Platinum is used by behavioral health staff and providers in the ambulatory mental and behavioral health setting. This is the sole care setting in which the product is deployed, and it is therefore the only care setting addressed by this report. Real World Testing activity for CY2025 was conducted across this setting, and the functionality under test is identical for every provider and practice within it.
Metrics and outcomes
| Measurement / metric | Associated criterion | Relied upon software | Outcomes | Challenges encountered |
|---|---|---|---|---|
|
Measure 1 Single patient electronic health information (EHI) export. |
§170.315(b)(10) | MeldRx ver. 2.0 | Not reported for CY2025 per the ONC Real World Testing Enforcement Discretion Notice. See “Changes to Original Plan” above. | NA |
|
Measure 2 C-CDA documents created and successfully sent to or received from a third party via Direct messaging during a transition of care event. |
§170.315(b)(1) | DataMotion Direct ver. 6.6 | Not reported for CY2025 per the ONC Real World Testing Enforcement Discretion Notice. See “Changes to Original Plan” above. | NA |
|
Measure 3 Patient access to a complete summary record via a third-party application connecting to the certified API, for a specific date and for a specified date range. |
§170.315(g)(9) | MeldRx ver. 2.0 |
Organic real-world usage, CY2025 Denominator — third-party application requests to the §170.315(g)(9) API received during CY2025: 0 Numerator — requests successfully fulfilled: 0 Success rate: not applicable; no requests were received. No patient- or provider-initiated third-party application requests occurred during the reporting period. This zero result reflects the actual real-world experience of our customers and their patients, and has not been substituted with an artificial transaction count. Supplemental functional validation Corrective-action validation performed after the reporting period, on September 22, 2026. Denominator — validation transactions attempted: 6 Numerator — transactions successfully completed: 6 Success rate: 100% Because organic usage did not occur, supplemental validation was performed using synthetic patient data in an environment mirroring production, as provided for in the ONC Real World Testing Resource Guide (October 2025), page 22, “Non-deployed and/or Low Use Capabilities.” Postman was used to represent the third-party application, operating against a conformant synthetic test patient that passes the ONC Edge Test Tool and carries the required USCDI data elements. The six validation transactions were:
The two negative controls were included to confirm that date and date-range filtering operates correctly, rather than returning results irrespective of the requested period. The returned document was verified as a C-CDA Release 2.1 summary record (LOINC 34133-9, Summarization of Episode Note) containing 19 sections spanning the USCDI data classes. The document date corresponded to the requested period and the record target corresponded to the requested patient. This validation was performed after the close of CY2025 and is identified as corrective-action validation. It is not presented as a CY2025 transaction. |
No technical failures occurred. The challenge was the absence of organic customer usage during the reporting period, addressed under “Changes to Original Plan.” |
Schedule of key milestones
| Key milestone | Care setting | Date / timeframe |
|---|---|---|
| Real World Testing period for CY2025 | Ambulatory | January 1 – December 31, 2025 |
| Monitoring of §170.315(g)(9) API activity across production customer sites | Ambulatory | Ongoing, CY2025 |
| Analysis of CY2025 Real World Testing results | Ambulatory | January 2026 |
| Initial CY2025 Real World Testing results report submitted to ONC-ACB | Ambulatory | January 29, 2026 |
| Supplemental functional validation of §170.315(g)(9) performed using synthetic patient data | Ambulatory | September 22, 2026 |
| Revised CY2025 Real World Testing results report submitted to ONC-ACB | Ambulatory | September 2026 |